| After Hours: | Change:
After Market Change
|
Volume: | Time: |
| Last | Change (%) | Trade Time | Bid (size) | Ask (size) | Day Volume |
|---|---|---|---|---|---|
Change
|
|||||
| Latest Tick | Prev Close | Open | Low | High | Avg Day Vol (30d) |
| Market Cap | P/E Ratio | EPS (TTM) | 52 Wk Low | 52 Wk High | # of Trades |
| Yield | Dividend | Ex Div Date | Exchange | Last Size | Avg Trade Size |
| Avg Trade Size |
News
LATEST TWEETS - CURATED BY HASH FINANCE
10x Genomics up 1.5% = $86.9 million gain. $TXG has made notable gains in 11 of the last 21 trading sessions, 6 day… https://t.co/3V3Zr33kJg
@bradloncar @FTLiveHealth GREAT company and product. The Bio-Rad ( $BIO ) NextGEM litigation situation is a big overhang though.
$TXG
$TXG Co-Founder and CEO Serge Saxonov. Largest healthcare IPO of the year. @FTLiveHealth #FTPharma https://t.co/T11CIY3zX7
$TXG - 10x Genomics Inc. (TXG) CEO Serge Saxonov on Q3 2019 Results - Earnings Call Transcript. Keep reading:… https://t.co/Epmo4BVeZe
In Quant Model Universe, growth outpeformed yclicals by 1.3% to -.6%. The cyclicals appear to reached a plateau; fu… https://t.co/CvdcIdGj2q
10x Genomics up 8.2% = $435.7 million gain. $TXG has made notable gains in 10 of the last 19 trading sessions, 6 da… https://t.co/WujvlRiMzV
